Rice Hall James & Associates LLC Invests $667,000 in Corteva, Inc. $CTVA

Rice Hall James & Associates LLC purchased a new position in Corteva, Inc. (NYSE:CTVAFree Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 7,876 shares of the company’s stock, valued at approximately $667,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. William B. Walkup & Associates Inc. grew its stake in Corteva by 2.9% during the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after buying an additional 126 shares during the last quarter. Wilkerson Advisory Group LLC lifted its stake in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after buying an additional 133 shares during the last quarter. AdvisorNet Financial Inc boosted its holdings in shares of Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after acquiring an additional 135 shares during the period. First Horizon Corp boosted its holdings in shares of Corteva by 9.2% during the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares during the period. Finally, Aviance Capital Partners LLC grew its position in shares of Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after acquiring an additional 137 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

CTVA has been the topic of several analyst reports. BNP Paribas Exane raised their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Morgan Stanley upped their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Barclays increased their price objective on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Mizuho boosted their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Check Out Our Latest Stock Analysis on CTVA

Corteva Stock Performance

Shares of CTVA opened at $77.97 on Wednesday. The firm’s 50 day moving average is $81.84 and its 200-day moving average is $80.12. The stock has a market capitalization of $52.02 billion, a P/E ratio of 51.64, a P/E/G ratio of 2.35 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.

Corteva (NYSE:CTVAGet Free Report) last released its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 47.68%.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.